What does CUSIP 92847N103 represent in this 13F holders report?

CUSIP 92847N103 is the security identifier for VTAE - VITAE PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held VTAE - VITAE PHARMACEUTICALS INC - COM in Q3 2015?

64 institutional investors reported VTAE - VITAE PHARMACEUTICALS INC - COM for Q3 2015. Use the holders table for investor-level position and value details.

VITAE PHARMACEUTICALS INC - COM (VTAE)

CUSIP: 92847N103

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class: Equity / COM
Total 13F shares: 14,113,672
Share change: +848,645
Total reported value: $155,390,109
Price per share: $11.01
Number of holders: 64
Value change: +$77,169
Number of buys: 46
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 92847N103?
CUSIP 92847N103 identifies VTAE - VITAE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2015
Previous quarter: Q2 2015

Recent filing periods for CUSIP 92847N103:

Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015 Q2 2015 Q1 2015

Institutional Holders of VITAE PHARMACEUTICALS INC - COM (VTAE) as of Q3 2015

As of 30 Sep 2015, VITAE PHARMACEUTICALS INC - COM (VTAE) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,113,672 shares. The largest 10 holders included FMR LLC, BVF INC/IL, ADAGE CAPITAL PARTNERS GP LLC, AWM Investment Company, Inc., MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., JPMORGAN CHASE & CO, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and BlackRock Fund Advisors. This page lists 64 institutional shareholders reporting positions in this security for the Q3 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.